ABIN358774
antibody from antibodies-online
Targeting: MTOR
FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN358774 - Provider product page

- Provider
- antibodies-online
- Product name
- anti-Mechanistic Target of Rapamycin (serine/threonine Kinase) (FRAP1) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody is generated from rabbits immunized with a KLH conjugated syntheticpeptide corresponding to amino acid residues surrounding S2481 of human FRAP1.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mg
- Concentration
- 0.25 mg/ml
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch. Caution: This product is for research use only. Not for use in diagnostic or therapeutic procedures.
Submitted references Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38.
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Bai X, Ma D, Liu A, Shen X, Wang QJ, Liu Y, Jiang Y
Science (New York, N.Y.) 2007 Nov 9;318(5852):977-80
Science (New York, N.Y.) 2007 Nov 9;318(5852):977-80
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.
Dowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N
Cancer research 2007 Nov 15;67(22):10804-12
Cancer research 2007 Nov 15;67(22):10804-12
No comments: Submit comment
No validations: Submit validation data